Drug Type Small molecule drug |
Synonyms Naltrexone/fluoxetine |
Target |
Mechanism Opioid receptors antagonists(Opioid receptors antagonists), SERT inhibitors(Serotonin transporter inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseDiscontinuedPhase 2 |
First Approval Date- |
Regulation- |
Molecular FormulaC17H19ClF3NO |
InChIKeyGIYXAJPCNFJEHY-UHFFFAOYSA-N |
CAS Registry56296-78-7 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Obsessive-Compulsive Disorder | Phase 2 | US | - |